Comparison between Dipna Pharmachem IPO and JFL Life Sciences IPO.
Dipna Pharmachem IPO is a SME Fixed Price IPO proposed to list at BSE SME while JFL Life Sciences IPO is a SME Fixed Price proposed to list at NSE SME.
| Dipna Pharmachem IPO | JFL Life Sciences IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Interactive Financial Services Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Sernet Financial Services Pvt.Ltd. | Econo Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dipna Pharmachem IPO is up to ₹14.43 Cr whereas the issue size of the JFL Life Sciences IPO is up to ₹17.25 Cr. The final issue price of Dipna Pharmachem IPO is ₹38.00 per share and of JFL Life Sciences IPO is ₹61.00 per share.
| Dipna Pharmachem IPO | JFL Life Sciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹38.00 per share | ₹61.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 2000 shares |
| Fresh Issue Size | 37,98,000 shares | 28,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹14.43 Cr | up to ₹17.25 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 37,98,000 shares | 28,28,000 shares |
| Issue Size Total (Amount) | up to ₹14.43 Cr | up to ₹17.25 Cr |
Dipna Pharmachem IPO opens on Aug 25, 2022, while JFL Life Sciences IPO opens on Aug 25, 2022. The closing date of Dipna Pharmachem IPO and JFL Life Sciences IPO is Aug 30, 2022, and Aug 30, 2022, respectively.
| Dipna Pharmachem IPO | JFL Life Sciences IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 25, 2022 | Aug 25, 2022 |
| Issue Close | Aug 30, 2022 | Aug 30, 2022 |
| Basis Of Allotment (Tentative) | Sep 05, 2022 | |
| Initiation of Refunds (Tentative) | Sep 06, 2022 | |
| Credit of Share (Tentative) | Sep 07, 2022 | |
| Listing date (Tentative) | Sep 08, 2022 | Sep 08, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dipna Pharmachem IPO P/E ratio is 39, as compared to JFL Life Sciences IPO P/E ratio of 26.52.
| Dipna Pharmachem IPO | JFL Life Sciences IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 92.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.56 | 67.47 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 39 | 26.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹45.49 Cr. | ₹67.09 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹333.40 | ₹0.89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 67.12 | 7.89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dipna Pharmachem IPO Retail Individual Investors (RII) are offered 18,99,000 shares while in JFL Life Sciences IPO retail investors are offered 18,99,000 shares. Qualified Institutional Buyers (QIB) are offered in Dipna Pharmachem IPO and in JFL Life Sciences IPO.
| Dipna Pharmachem IPO | JFL Life Sciences IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,04,000 shares | 1,50,000 shares |
| QIB | ||
| NII | 18,99,000 shares | 14,14,000 shares |
| RII | 18,99,000 shares | 14,14,000 shares |
| Employee | ||
| Others | ||
| Total | 37,98,000 shares | 28,28,000 shares |
Dipna Pharmachem IPO subscribed 2.77x in total, whereas JFL Life Sciences IPO subscribed 8.93x.
| Dipna Pharmachem IPO | JFL Life Sciences IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.78x | 6.19x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.75x | 11.66x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.77x | 8.93x |
